vs
Side-by-side financial comparison of KILROY REALTY CORP (KRC) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
KILROY REALTY CORP is the larger business by last-quarter revenue ($272.2M vs $250.2M, roughly 1.1× USANA HEALTH SCIENCES INC). KILROY REALTY CORP runs the higher net margin — 6.3% vs 3.0%, a 3.3% gap on every dollar of revenue. On growth, USANA HEALTH SCIENCES INC posted the faster year-over-year revenue change (-3.0% vs -5.0%). Over the past eight quarters, USANA HEALTH SCIENCES INC's revenue compounded faster (11.8% CAGR vs -1.2%).
Kilroy Realty Corp is a leading U.S. real estate investment trust that develops, owns, and operates premium office, life science, and mixed-use properties primarily across high-growth West Coast markets including Los Angeles, San Francisco, Seattle, and San Diego. It serves tenants across the technology, life sciences, media, and creative sectors, with a core focus on delivering sustainable, future-ready workspaces tailored to modern business needs.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
KRC vs USNA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2027
| Metric | | |
|---|---|---|
| Revenue | $272.2M | $250.2M |
| Net Profit | $17.1M | $7.5M |
| Gross Margin | — | 76.2% |
| Operating Margin | — | 5.5% |
| Net Margin | 6.3% | 3.0% |
| Revenue YoY | -5.0% | -3.0% |
| Net Profit YoY | -73.7% | -20.0% |
| EPS (diluted) | $0.11 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $250.2M | ||
| Q4 25 | $272.2M | $226.2M | ||
| Q3 25 | $279.7M | $213.7M | ||
| Q2 25 | $289.9M | $235.8M | ||
| Q1 25 | $270.8M | $249.5M | ||
| Q4 24 | $286.4M | $213.6M | ||
| Q3 24 | $289.9M | $200.2M | ||
| Q2 24 | $280.7M | — |
| Q1 26 | — | $7.5M | ||
| Q4 25 | $17.1M | $180.0K | ||
| Q3 25 | $162.3M | $-6.5M | ||
| Q2 25 | $79.6M | $9.7M | ||
| Q1 25 | $43.7M | $9.4M | ||
| Q4 24 | $65.0M | $4.5M | ||
| Q3 24 | $57.7M | $10.6M | ||
| Q2 24 | $54.5M | — |
| Q1 26 | — | 76.2% | ||
| Q4 25 | — | 78.2% | ||
| Q3 25 | — | 77.2% | ||
| Q2 25 | — | 78.7% | ||
| Q1 25 | — | 79.0% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | — | 80.4% | ||
| Q2 24 | — | — |
| Q1 26 | — | 5.5% | ||
| Q4 25 | — | 1.7% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 7.1% | ||
| Q1 25 | — | 6.3% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | — |
| Q1 26 | — | 3.0% | ||
| Q4 25 | 6.3% | 0.1% | ||
| Q3 25 | 58.0% | -3.1% | ||
| Q2 25 | 27.4% | 4.1% | ||
| Q1 25 | 16.1% | 3.8% | ||
| Q4 24 | 22.7% | 2.1% | ||
| Q3 24 | 19.9% | 5.3% | ||
| Q2 24 | 19.4% | — |
| Q1 26 | — | $0.41 | ||
| Q4 25 | $0.11 | $-0.10 | ||
| Q3 25 | $1.31 | $-0.36 | ||
| Q2 25 | $0.57 | $0.52 | ||
| Q1 25 | $0.33 | $0.49 | ||
| Q4 24 | $0.50 | $0.23 | ||
| Q3 24 | $0.44 | $0.56 | ||
| Q2 24 | $0.41 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $179.3M | $162.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.4B | — |
| Total Assets | $10.9B | $739.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $162.8M | ||
| Q4 25 | $179.3M | $158.4M | ||
| Q3 25 | $372.4M | $145.3M | ||
| Q2 25 | $193.1M | $151.3M | ||
| Q1 25 | $146.7M | $179.6M | ||
| Q4 24 | $165.7M | $181.8M | ||
| Q3 24 | $625.4M | $364.9M | ||
| Q2 24 | $835.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | $5.4B | — | ||
| Q3 25 | $5.5B | $528.1M | ||
| Q2 25 | $5.4B | $531.1M | ||
| Q1 25 | $5.4B | $529.8M | ||
| Q4 24 | $5.4B | $532.1M | ||
| Q3 24 | $5.4B | $533.1M | ||
| Q2 24 | $5.4B | — |
| Q1 26 | — | $739.0M | ||
| Q4 25 | $10.9B | $742.9M | ||
| Q3 25 | $11.0B | $726.6M | ||
| Q2 25 | $10.9B | $734.5M | ||
| Q1 25 | $10.9B | $746.6M | ||
| Q4 24 | $10.9B | $748.2M | ||
| Q3 24 | $11.4B | $671.3M | ||
| Q2 24 | $11.5B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $566.3M | — |
| Free Cash FlowOCF − Capex | $450.3M | — |
| FCF MarginFCF / Revenue | 165.4% | — |
| Capex IntensityCapex / Revenue | 42.6% | — |
| Cash ConversionOCF / Net Profit | 33.10× | — |
| TTM Free Cash FlowTrailing 4 quarters | $833.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $566.3M | — | ||
| Q3 25 | $176.6M | $-2.0M | ||
| Q2 25 | $143.7M | $12.2M | ||
| Q1 25 | $136.9M | $15.5M | ||
| Q4 24 | $541.1M | $5.8M | ||
| Q3 24 | $176.3M | $29.5M | ||
| Q2 24 | $88.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | $450.3M | — | ||
| Q3 25 | $148.7M | $-5.2M | ||
| Q2 25 | $118.4M | $7.2M | ||
| Q1 25 | $115.6M | $12.7M | ||
| Q4 24 | $440.8M | $4.0M | ||
| Q3 24 | $147.2M | $27.1M | ||
| Q2 24 | $69.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | 165.4% | — | ||
| Q3 25 | 53.1% | -2.4% | ||
| Q2 25 | 40.9% | 3.0% | ||
| Q1 25 | 42.7% | 5.1% | ||
| Q4 24 | 153.9% | 1.9% | ||
| Q3 24 | 50.8% | 13.6% | ||
| Q2 24 | 24.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 42.6% | — | ||
| Q3 25 | 10.0% | 1.5% | ||
| Q2 25 | 8.7% | 2.1% | ||
| Q1 25 | 7.9% | 1.1% | ||
| Q4 24 | 35.0% | 0.8% | ||
| Q3 24 | 10.1% | 1.2% | ||
| Q2 24 | 6.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | 33.10× | — | ||
| Q3 25 | 1.09× | — | ||
| Q2 25 | 1.81× | 1.27× | ||
| Q1 25 | 3.13× | 1.65× | ||
| Q4 24 | 8.32× | 1.29× | ||
| Q3 24 | 3.06× | 2.78× | ||
| Q2 24 | 1.63× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
